PRESS RELEASES - 2005 Archive
Wheat Ridge, Colorado
Bolder BioTechnology Awarded NIH Phase I SBIR Grant to Develop Bioscavenger Protein for Detoxifying Nerve Agents
>>Click here for complete News Release
8-12-2005
Wheat Ridge, Colorado
Bolder BioTechnology Receives Funding from the National Cancer Institute to Evaluate Efficacy of a Second Generation Interferon Gamma Protein for Treating Ovarian Cancer
>>Click here for complete News Release
5-18-2005
Wheat Ridge, Colorado
Bolder BioTechnology Receives NIH Grant to Develop Second Generation Infection Fighting Protein
>>Click here for complete News Release
2-01-2005
Wheat Ridge, Colorado
Bolder BioTechnology Receives U.S. Patent for Process used to Manufacture Proprietary Second-Generation Protein Pharmaceuticals
>>Click here for complete News Release
1-20-2005
Wheat Ridge, Colorado
Bolder BioTechnology Awarded NIH Grant to Develop Novel Arthritis Treatment
>>Click here for complete News Release
1-13-2005
Wheat Ridge, Colorado
Bolder BioTechnology Receives NIH Grant for Preclinical Development of Proprietary Erythropoiesis-Stimulating Protein
>>Click here for complete News Release
1-12-2005
Wheat Ridge, Colorado
Bolder BioTechnology Receives NIH Grant for Preclinical Development of Second Generation Growth Hormone Product
>>Click here for complete News Release
Back to News
About Us - Technology - Products - People - News - Careers - Contact Us
Copyright © 2008. Bolder BioTechnology, Inc. All Rights Reserved.
powered by
Disclaimer
iCita